Nuveen’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.35M Buy
97,120
+704
+0.7% +$9.65K ﹤0.01% 2432
2025
Q4
$1.33M Buy
96,416
+787
+0.8% +$18.5K ﹤0.01% 2470
2025
Q3
$2.34M Sell
95,629
-346
-0.4% -$8.43K ﹤0.01% 2241
2025
Q2
$2.22M Sell
95,975
-27,704
-22% -$730K ﹤0.01% 2258
2025
Q1
$3.34M Sell
123,679
-4,068
-3% -$153K ﹤0.01% 2125
2024
Q4
$6.84M Sell
127,747
-39,145
-23% -$2.07M ﹤0.01% 1824
2024
Q3
$7.58M Sell
166,892
-230,014
-58% -$10M ﹤0.01% 1773
2024
Q2
$16.6M Buy
396,906
+318,281
+405% +$14.9M ﹤0.01% 1251
2024
Q1
$2.96M Sell
78,625
-2,949
-4% -$64.2K ﹤0.01% 2215
2023
Q4
$875K Buy
81,574
+14,872
+22% +$129K ﹤0.01% 2796
2023
Q3
$672K Buy
66,702
+7,957
+14% +$91.8K ﹤0.01% 2736
2023
Q2
$697K Buy
58,745
+12,842
+28% +$172K ﹤0.01% 2816
2023
Q1
$555K Sell
45,903
-14,814
-24% -$247K ﹤0.01% 2785
2022
Q4
$799K Sell
60,717
-12,160
-17% -$178K ﹤0.01% 2763
2022
Q3
$987K Sell
72,877
-1,996
-3% -$26.7K ﹤0.01% 2758
2022
Q2
$915K Buy
74,873
+49,213
+192% +$583K ﹤0.01% 2825
2022
Q1
$392K Buy
25,660
+6,203
+32% +$101K ﹤0.01% 3071
2021
Q4
$345K Hold
19,457
﹤0.01% 3147
2021
Q3
$421K Buy
+19,457
New +$560K ﹤0.01% 3200

Other funds holding JANX